ETHEPHON - Keresési eredmények

Európai Unió - magyar - EMA (European Medicines Agency)

bimervax

hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - a vakcinák - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.

Európai Unió - magyar - EMA (European Medicines Agency)

pombiliti

amicus therapeutics europe limited - cipaglucosidase alfa - ii típusú glikogén-tároló betegség - egyéb táplálkozási traktus pedig anyagcsere termékek, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Európai Unió - magyar - EMA (European Medicines Agency)

omvoh

eli lilly nederland b.v. - mirikizumab - colitis, ulceratív - immunszuppresszánsok - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

Európai Unió - magyar - EMA (European Medicines Agency)

abrysvo

pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - légzőszervi szinciális vírusfertőzések - a vakcinák - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. lásd a 4. 2 és 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. használja ezt a vakcinát a hivatalos ajánlásoknak megfelelően.